Howard J. Federoff
Affiliations: | Center for Aging and Developmental Biology | University of Rochester Medical Center, Rochester, NY, United States |
Google:
"Howard Federoff"Mean distance: 15.7 (cluster 11)
Children
Sign in to add trainee| Marc W. Halterman | grad student | 2002 | Rochester |
| Brandon K. Harvey | grad student | 2003 | Rochester |
| Kuei-Cheng Lim | grad student | 2005 | Rochester |
| Jill M. Weimer | grad student | 2006 | Rochester |
| Charles A. Wuertzer | grad student | 2006 | Rochester |
| Carolyn M. Tyler | grad student | 2003-2006 | University of Rochester Medical Center |
| Jason A. Hamilton | grad student | 2007 | Rochester |
| Xiaomin Su | grad student | 2008 | Rochester |
| William J. Bowers | post-doc | 1995-1999 | University of Rochester Medical Center |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Heiss JD, Lungu C, Hammoud DA, et al. (2019) Trial of magnetic resonance-guided putaminal gene therapy for advanced Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society |
| Subramaniam SR, Federoff HJ. (2017) Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease. Frontiers in Aging Neuroscience. 9: 176 |
| Su X, Fischer DL, Li X, et al. (2017) Alpha-Synuclein mRNA Is Not Increased. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Su X, Chu Y, Kordower JH, et al. (2015) PGC-1α Promoter Methylation in Parkinson's Disease. Plos One. 10: e0134087 |
| Gustafsson M, Nestor CE, Zhang H, et al. (2014) Modules, networks and systems medicine for understanding disease and aiding diagnosis. Genome Medicine. 6: 82 |
| Su X, Federoff HJ. (2014) Immune responses in Parkinson's disease: interplay between central and peripheral immune systems. Biomed Research International. 2014: 275178 |
| Fiandaca MS, Federoff HJ. (2014) Using viral-mediated gene delivery to model Parkinson's disease: do nonhuman primate investigations expand our understanding? Experimental Neurology. 256: 117-25 |
| Huang L, Su X, Federoff HJ. (2013) Single-chain fragment variable passive immunotherapies for neurodegenerative diseases. International Journal of Molecular Sciences. 14: 19109-27 |
| Huang L, Shimoji M, Wang J, et al. (2013) Development of inducible leucine-rich repeat kinase 2 (LRRK2) cell lines for therapeutics development in Parkinson's disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 10: 840-51 |
| MacArthur L, Ressom H, Shah S, et al. (2013) Network modeling to identify new mechanisms and therapeutic targets for Parkinson's disease. Expert Review of Neurotherapeutics. 13: 685-93 |